Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: does lenalidomide protect from severe COVID-19?
Publication date: Available online 16 September 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Imran K. Tailor, Nawal F. Alshehry, Syed Z. Zaidi, Mohammed A. Marei, Ibrahim H. Motabi, Mansour Alfayez, Syed Y. Altaf
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | COVID-19 | Hematology | Myeloma | Revlimid | Stem Cell Therapy | Stem Cells